Tools for informed decisions
GLP-1 & weight management calculators
Explore BMI, put a quote in context, and understand what a percentage change means. Practical tools for your next conversation with a clinician.
Adult BMI calculator
Body mass index puts weight in relation to height. For adults aged 20 and older, it is one screening measure—not a diagnosis, a measure of body fat, or permission to start medication. [1] [2]
Method: BMI = kg ÷ height in metres squared; or lb ÷ height in inches squared × 703. The US formula uses CDC’s rounded conversion factor, so small differences between unit systems are possible. Categories use the unrounded result. [1] [2]
Adult categories are not appropriate for children or teens. During pregnancy, use clinician guidance based on pre-pregnancy BMI rather than interpreting current gestational weight here. BMI alone cannot establish medication eligibility. [3] [4]
Cost & budget planner
A monthly medication price may not be the whole bill. Enter a current quote or your actual out-of-pocket costs to see what recurring and one-time charges add up to. These fields do not contain Luma prices or competitor offers.
Method: total = (medication + care/membership + shipping + other monthly costs) × months + one-time costs. Average monthly cost = total ÷ months. Dollar entries are rounded to cents before adding.
Enter costs after any confirmed insurance contribution; this tool cannot estimate coverage, deductibles, eligibility or reimbursement. It assumes the same recurring cost each month and does not infer discounts, dose changes, taxes or cancellation terms. For a four-week supply, confirm how that billing cycle differs from a calendar month before entering a monthly amount.
Verify current program details on Luma’s pricing page or use the affordability comparison guide. Using this planner does not create a quote, charge, prescription or enrollment.
Weight-change scenario
Choose a percentage to understand its arithmetic meaning. The result is hypothetical: it does not say what you will lose, what you should aim for, or when a change could happen.
Method: amount changed = starting weight × percentage ÷ 100. Scenario weight = starting weight − amount changed. The same formula works in pounds or kilograms.
For adults with overweight or obesity, even modest weight loss can have health benefits, but personal goals need context. A trial average is not an individual forecast, and results from approved branded products cannot establish outcomes for a compounded preparation. [5] [8]
Open the full weight-change calculator and methodology for an explanation of percentages and uncertainty.
Branded injection dosing reference
This is a reading guide to labeled adult weight-management dosing—not a dose calculator or a personal treatment schedule. It does not apply to compounded products, Wegovy tablets, Ozempic or Mounjaro. Do not start, increase, stop or switch treatment based on this page.
Wegovy injection
Adult weight-management reference; all amounts below are once-weekly subcutaneous doses. [6]
| Labeled stage | Injection dose |
|---|---|
| Weeks 1–4 | 0.25 mg once weekly |
| Weeks 5–8 | 0.5 mg once weekly |
| Weeks 9–12 | 1 mg once weekly |
| Weeks 13–16 | 1.7 mg once weekly |
| Adult weight-management maintenance | 2.4 mg recommended, or 1.7 mg once weekly, selected by the prescriber |
Your prescriber considers response and tolerability. The label allows considering a four-week delay in escalation if a dose is not tolerated. This table is not an instruction to increase automatically.
Zepbound injection
Adult weight-management reference; amounts are once-weekly subcutaneous doses. [7]
| Labeled stage | Injection dose |
|---|---|
| Initiation, first 4 weeks | 2.5 mg once weekly; not a maintenance dose |
| After the first 4 weeks | 5 mg once weekly |
| Further escalation, if prescribed | 2.5 mg increments after at least 4 weeks on the current dose |
| Weight-management maintenance | 5 mg, 10 mg or 15 mg once weekly |
| Maximum labeled dose | 15 mg once weekly |
Not everyone needs or tolerates the highest dose. Your prescriber selects maintenance based on response and tolerability; the label allows considering a lower maintenance dose if needed.
These labels carry a boxed warning about thyroid C-cell tumors observed in rodents; relevance in humans is unknown. Both medicines are contraindicated with a personal or family history of medullary thyroid carcinoma, MEN 2, or a serious allergy to the product. Weight-loss treatment is not appropriate during pregnancy; discuss pregnancy plans before treatment. This is not a complete safety list. [6] [7]
Seek urgent care for severe persistent abdominal pain, serious dehydration or concerning symptoms. Call emergency services for breathing difficulty, facial/throat swelling, or another suspected severe allergic reaction.
Start a conversation.
A number is a starting point, not a treatment decision. Review health history, medications, goals and concerns with a licensed clinician.
Check the details.
Quotes, coverage and prescribing information can change. Confirm the exact product, dose and program terms rather than assuming every option is the same.
Keep results in context.
These tools provide education and arithmetic. They do not diagnose a condition, promise results, determine eligibility or replace follow-up care.
Calculations run in your browser. These tools do not save or submit your entries. Standard site analytics remain in place; see the privacy policy.
Methods & sources
Sources checked September 16, 2026. Labels and guidance can change; consult current prescribing information and your clinician.
- CDC: BMI formulas and frequently asked questions
- CDC: adult BMI categories
- CDC: weight gain during pregnancy
- NIDDK: prescription medications to treat overweight and obesity
- CDC: steps for losing weight
- FDA: Wegovy prescribing information, injection sections
- Eli Lilly: Zepbound prescribing information
- FDA: concerns with unapproved GLP-1 drugs used for weight loss